Gemini Therapeutics is a product engine company focused on redefining AMD and linked disorders with precision medicine. Our ocular therapeutic candidates are matched to molecular abnormalities found in patients with high clinical need and our multimodal product engine has generated a rich pipeline including monoclonal antibodies, recombinant proteins and gene therapies.